- Report
- November 2024
- 750 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- February 2025
- 218 Pages
Global
From €4191EUR$4,799USD£3,641GBP
- Report
- August 2025
- 154 Pages
Global
From €2314EUR$2,650USD£2,010GBP
- Report
- June 2025
- 379 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- June 2025
- 151 Pages
Global
From €3057EUR$3,500USD£2,655GBP
- Report
- February 2025
- 153 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- April 2025
- 100 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- May 2025
- 200 Pages
Global
From €2175EUR$2,490USD£1,889GBP
- Report
- March 2025
- 200 Pages
Global
From €2175EUR$2,490USD£1,889GBP
- Report
- April 2025
- 147 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- March 2025
- 149 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- January 2025
- 132 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- March 2025
- 200 Pages
Global
From €2175EUR$2,490USD£1,889GBP
- Report
- August 2025
- 192 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 183 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 187 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 192 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 193 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 193 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more